Antitumor Effects of Vitamin D Analogs on Hamster and Mouse Melanoma Cell Lines in Relation to Melanin Pigmentation
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Deregulated melanogenesis is involved in melanomagenesis and melanoma progression and resistance to therapy. Vitamin D analogs have anti-melanoma activity. While the hypercalcaemic effect of the active form of Vitamin D (1,25(OH)2D3) limits its therapeutic use, novel Vitamin D analogs with a modified side chain demonstrate low calcaemic activity. We therefore examined the effect of secosteroidal analogs, both classic (1,25(OH)2D3 and 25(OH)D3), and novel relatively non-calcemic ones (20(OH)D3, calcipotriol, 21(OH)pD, pD and 20(OH)pL), on proliferation, colony formation in monolayer and soft-agar, and mRNA and protein expression by melanoma cells. Murine B16-F10 and hamster Bomirski Ab cell lines were shown to be effective models to study how melanogenesis affects anti-melanoma treatment. Novel Vitamin D analogs with a short side-chain and lumisterol-like 20(OH)pL efficiently inhibited rodent melanoma growth. Moderate pigmentation sensitized rodent melanoma cells towards Vitamin D analogs, and altered expression of key genes involved in Vitamin D signaling, which was opposite to the effect on heavily pigmented cells. Interestingly, melanogenesis inhibited ligand-induced Vitamin D receptor translocation and ligand-induced expression of VDR and CYP24A1 genes. These findings indicate that melanogenesis can affect the anti-melanoma activity of Vitamin D analogs in a complex manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melanin pigmentation in mammalian skin and its hormonal regulation
Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00044.2003 · Cited by 2,015 · cited 2×
“Melanin pigmentation, a marker of melanocyte differentiation, affects cellular metabolism and behavior [13,47,48].”
BackgroundSelf-citationVitamin D: a millenium perspective
Holick, M. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10338 · Cited by 1,319 · cited 2×
“Despite its antiproliferative properties, the use of 1,25(OH)2D3 as a therapeutic agent at supra-physiological concentrations (above 50,000 units a day) is limited due to its hypercalcemic effects [4,12].”
BackgroundSunlight and Vitamin D: A global perspective for health
Wacker, M., & Holick, M. F. (2013) · Dermato-Endocrinology · doi:10.4161/derm.24494 · Cited by 1,156
Steroidogenesis in the skin: Implications for local immune functions
Slominski, A., Zbytek, B., Nikolakis, G., Manna, P. R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C. C., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.006 · Cited by 369 · cited 1×
“Pleiotropic effects of 1,25(OH)2D3 include enhancement of DNA repair processes, protection against reactive oxygen species (ROS) and immunomodulation [6–8].”
BackgroundSelf-citationNovel activities of CYP11A1 and their potential physiological significance
Slominski, A. T., Li, W., Kim, T.-K., Semak, I., Wang, J., Zjawiony, J. K., & Tuckey, R. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.010 · Cited by 292 · cited 1×
“Recently, we discovered a new metabolic pathway of Vitamin D activation producing novel analogs, including 20-hydroxyvitamin D3 (20(OH)D3) (reviewed in [40,41]), which can operate in vivo [42], with the products showing strong antileukemic and anticancer activities in vitro (reviewed in [19,34,35,40]) while being nonc…”
BackgroundSelf-citationSlominski, A. T., Kim, T., Shehabi, H. Z., Semak, I., Tang, E. K. Y., Nguyen, M. N., Benson, H. A. E., Korik, E., Janjetovic, Z., Chen, J., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-208975 · Cited by 266 · cited 2×
“Recently, we discovered a new metabolic pathway of Vitamin D activation producing novel analogs, including 20-hydroxyvitamin D3 (20(OH)D3) (reviewed in [40,41]), which can operate in vivo [42], with the products showing strong antileukemic and anticancer activities in vitro (reviewed in [19,34,35,40]) while being nonc…”
BackgroundSelf-citationMelanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
Brożyna, A. A., Jóźwicki, W., Carlson, J. A., & Slominski, A. T. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.02.022 · Cited by 175 · cited 2×
“Although limited literature is available on the influence of melanin pigmentation on melanoma therapy, it has been demonstrated that melanogenesis shortens overall- and disease free-survival of patients with stage III and IV disease [49,50].”
BackgroundSelf-citationSlominski, A. T., Kim, T.-K., Li, W., Yi, A.-K., Postlethwaite, A., & Tuckey, R. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.012 · Cited by 170 · cited 2×
“Recently, we discovered a new metabolic pathway of Vitamin D activation producing novel analogs, including 20-hydroxyvitamin D3 (20(OH)D3) (reviewed in [40,41]), which can operate in vivo [42], with the products showing strong antileukemic and anticancer activities in vitro (reviewed in [19,34,35,40]) while being nonc…”
BackgroundSelf-citationThe cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism
Slominski, A., Semak, I., Zjawiony, J., Wortsman, J., Li, W., Szczesniewski, A., & Tuckey, R. C. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04819.x · Cited by 155
Self-citationSlominski, A. T., Janjetovic, Z., Fuller, B. E., Zmijewski, M. A., Tuckey, R. C., Nguyen, M. N., Sweatman, T., Li, W., Zjawiony, J., Miller, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009907 · Cited by 149
Self-citationJanjetovic, Z., Zmijewski, M. A., Tuckey, R. C., DeLeon, D. A., Nguyen, M. N., Pfeffer, L. M., & Slominski, A. T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005988 · Cited by 130
Self-citationExpression of vitamin D receptor decreases during progression of pigmented skin lesions
Brożyna, A. A., Jozwicki, W., Janjetovic, Z., & Slominski, A. T. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.09.014 · Cited by 120 · cited 4×
“In highly pigmented melanomas, the efficacy of Vitamin D analogs decreases, probably as a result of diminished VDR expression [36,46,50].”
BackgroundResultSelf-citationPathways and products for the metabolism of vitamin D3 by cytochrome P450scc
Tuckey, R. C., Li, W., Zjawiony, J. K., Zmijewski, M. A., Nguyen, M. N., Sweatman, T., Miller, D., & Slominski, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06406.x · Cited by 118 · cited 1×
“20(OH)D2 and 20(OH)D3 analogs were also synthesized and purified as described previously [80–83].”
MethodSelf-citationZbytek, B., Janjetovic, Z., Tuckey, R. C., Zmijewski, M. A., Sweatman, T. W., Jones, E., Nguyen, M. N., & Slominski, A. T. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.62 · Cited by 118 · cited 1×
“In this paper, we report the differential anti-proliferative responses of pigmented and non-pigmented rodent melanoma cells to classical metabolites of Vitamin D (1,25(OH)2D3 and 25(OH)D3) and novel 20(OH)D3 [61] and calcipotriol [62], as well as short-side chain secosteroids, pD [63], 20(OH)pD, 20(OH)pL [64] and 21(O…”
BackgroundSelf-citationSlominski, A. T., Kim, T.-K., Shehabi, H. Z., Tang, E. K. Y., Benson, H. A. E., Semak, I., Lin, Z., Yates, C. R., Wang, J., Li, W., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.12.012 · Cited by 100 · cited 1×
“These compounds belong to a new class of endogenously produced Vitamin D analogs, with their 5,7-diene-like precursors potentially being made in the skin or other tissues [34,40–42,65].”
BackgroundSlominski, A., Semak, I., Wortsman, J., Zjawiony, J., Li, W., Zbytek, B., & Tuckey, R. C. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05302.x · Cited by 98
Self-citationJanjetovic, Z., Brozyna, A. A., Tuckey, R. C., Kim, T.-K., Nguyen, M. N., Jozwicki, W., Pfeffer, S. R., Pfeffer, L. M., & Slominski, A. T. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.458 · Cited by 91 · cited 5×
“We have already tested the in vitro activity of the major product of this pathway, 20(OH)D3, and its metabolites, finding that they show antiproliferative activity against cultured melanoma cells, acting as biased agonists on the VDR [43,45,46].”
BackgroundInfluentialSelf-citationNovel vitamin D photoproducts and their precursors in the skin
Slominski, A., Kim, T.-K., Zmijewski, M. A., Janjetovic, Z., Li, W., Chen, J., Kusniatsova, E. I., Semak, I., Postlethwaite, A., Miller, D. D., et al. (2013) · Dermato-Endocrinology · doi:10.4161/derm.23938 · Cited by 76
Self-citationBrożyna, A. A., Jóźwicki, W., Janjetovic, Z., & Slominski, A. T. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.03.031 · Cited by 70
Self-citationKim, T.-K., Wang, J., Janjetovic, Z., Chen, J., Tuckey, R. C., Nguyen, M. N., Tang, E. K. Y., Miller, D., Li, W., & Slominski, A. T. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.001 · Cited by 67
Self-citationZmijewski, M. A., Li, W., Zjawiony, J. K., Sweatman, T. W., Chen, J., Miller, D. D., & Slominski, A. T. (2009) · Steroids · doi:10.1016/j.steroids.2008.10.017 · Cited by 62 · cited 2×
“In this paper, we report the differential anti-proliferative responses of pigmented and non-pigmented rodent melanoma cells to classical metabolites of Vitamin D (1,25(OH)2D3 and 25(OH)D3) and novel 20(OH)D3 [61] and calcipotriol [62], as well as short-side chain secosteroids, pD [63], 20(OH)pD, 20(OH)pL [64] and 21(O…”
BackgroundMethodSelf-citationZmijewski, M. A., Li, W., Chen, J., Kim, T.-K., Zjawiony, J. K., Sweatman, T. W., Miller, D. D., & Slominski, A. T. (2011) · Steroids · doi:10.1016/j.steroids.2010.10.009 · Cited by 51
Self-citationMetabolism of vitamin D2 to 17, 20,24-trihydroxyvitamin D2 by cytochrome p450scc (CYP11A1)
Nguyen, M. N., Slominski, A., Li, W., Ng, Y. R., & Tuckey, R. C. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025619 · Cited by 48
Self-citationSynthesis and photo-conversion of androsta- and pregna-5,7-dienes to vitamin D3-like derivatives
Zmijewski, M. A., Li, W., Zjawiony, J. K., Sweatman, T. W., Chen, J., Miller, D. D., & Slominski, A. T. (2008) · Photochemical & Photobiological Sciences · doi:10.1039/b809005j · Cited by 41 · cited 1×
“In this paper, we report the differential anti-proliferative responses of pigmented and non-pigmented rodent melanoma cells to classical metabolites of Vitamin D (1,25(OH)2D3 and 25(OH)D3) and novel 20(OH)D3 [61] and calcipotriol [62], as well as short-side chain secosteroids, pD [63], 20(OH)pD, 20(OH)pL [64] and 21(O…”
BackgroundSelf-citation
Cited by
The serum vitamin D metabolome: what we know and what is still to discover
Tuckey, R. C., Cheng, C. Y. S., & Slominski, A. T. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.09.003 · Cited by 245
Self-citationSlominski, A. T., Kim, T.-K., Hobrath, J. V., Oak, A. S. W., Tang, E. K. Y., Tieu, E. W., Li, W., Tuckey, R. C., & Jetten, A. M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.09.024 · Cited by 143
Self-citationSlominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Self-citationSlominski, A. T., Kim, T.-K., Hobrath, J. V., Janjetovic, Z., Oak, A. S. W., Postlethwaite, A., Lin, Z., Li, W., Takeda, Y., Jetten, A. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10202-7 · Cited by 82
Self-citationVitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytes
Piotrowska, A., Wierzbicka, J., Ślebioda, T., Woźniak, M., Tuckey, R. C., Slominski, A. T., & Żmijewski, M. A. (2016) · Steroids · doi:10.1016/j.steroids.2016.04.002 · Cited by 48
“Importantly, 20(OH)D3, 21(OH)pD and calcipotriol have less or no influence on calcium levels compared to 1,25(OH)2D3 [8, 23, 24, 26, 116, 117], indicating biased effects on the VDR as proposed previously [8].”
BackgroundSelf-citation
Metadata
- Authors
- Wasiewicz, T., Szyszka, P., Cichorek, M., Janjetovic, Z., Tuckey, R., Slominski, A., & Zmijewski, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-03-24
- Volume
- 16
- Issue
- 4
- Pages
- 6645-6667
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2046192258
- Cited by
- 48
- References
- 24
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.